NCT00000877View on ClinicalTrials.gov

Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2000

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Rifabutin

Trial Locations (8)

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10021

Cornell Univ Med Ctr, New York

21287

Johns Hopkins Hosp, Baltimore

80262

Univ of Colorado Health Sciences Ctr, Denver

90033

Univ of Southern California / LA County USC Med Cntr, Los Angeles

331361013

Univ of Miami School of Medicine, Miami

462025250

Indiana Univ Hosp, Indianapolis

900331079

Univ of Southern California / LA County USC Med Ctr, Los Angeles

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH